Related Experiment Videos
[Balloon therapy of mitral stenosis]
M Brekke1, T O Kjellevand, G Smith
1Klinikk for medisinsk service, Ullevål sykehus, Oslo.
Summary
Percutaneous balloon mitral valvuloplasty effectively treated mitral stenosis in 12 Norwegian patients, significantly reducing pressure gradients and increasing valve area. One serious complication was successfully managed, with no restenosis observed at one-year follow-up.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Mitral stenosis is a significant valvular heart disease.
- Percutaneous balloon mitral valvuloplasty (PBMV) offers a less invasive treatment option.
Purpose of the Study:
- To describe the PBMV technique.
- To report the initial outcomes of PBMV in Norway.
- To discuss patient selection criteria.
Main Methods:
- PBMV was performed on 12 patients with mitral stenosis.
- Echocardiography was used for pre-procedure and follow-up assessments.
- Hemodynamic parameters (gradients, orifice area) were measured.
Main Results:
- Successful treatment in 11 of 12 patients; one serious complication was managed.
- Average maximal gradient decreased from 21 to 8 mm Hg.
- Average mean gradient decreased from 12 to 4 mm Hg.
- Average mitral valve orifice area increased from 1.0 to 2.2 cm².
- No restenosis was detected at one-year echocardiographic follow-up.
Conclusions:
- PBMV is a safe and effective treatment for mitral stenosis.
- The procedure leads to significant hemodynamic improvement.
- Long-term results appear favorable with no observed restenosis.